The dysregulated pathway as a result of the BRCA2 mutation resulted in genomic instability, which allowed tumor progression and proliferation via the NOTCH pathway, as seen in the patient with a BRCA2 mutation alongside an aberrant NOTCH2 [52]. The gene discussed is NOTCH2; the disease is neoplasm.